White House approves new COVID-19 vaccine standards after FDA publishes them anyway
The White House on Tuesday, in an apparent reversal, approved stringent new Food and Drug Administration guidelines for emergency use approval of a COVID-19 vaccine. The Trump administration was widely reported to have rejected the new guidelines Monday night, citing purported opposition from drugmakers and questioning whether the new standards were necessary. But President Trump had openly criticized the guidelines, which, now in force, will make it difficult but not impossible for a vaccine to get approval before Election Day.
The White House cleared the new standards shortly after the FDA unilaterally published them as part of its briefing materials for an upcoming meeting of its outside vaccine advisory committee, The Washington Post reports. Pfizer also endorsed the guidelines earlier on Tuesday, becoming the last U.S.-backed drugmaker with a late-stage vaccine to publicly signal support. The new standards aren't notably different from other vaccine approval standards, and the FDA created them in part to raise public confidence in COVID-19 vaccines amid politicization from the White House.
"The bottom line is, FDA is going to stick to the objective criteria that they outlined in the guidance, the [advisory committee] is going to support those principles, and the sponsors are going to adhere to them," former FDA Commissioner Scott Gottlieb said Tuesday at a symposium on vaccines and scientific integrity. "There are few moments I can think of where so much political dust was created by political officials for so little actual practical effect — and perhaps negative effect."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Trump still tweeted his disapproval Tuesday night, tagging FDA Commissioner Stephen Hahn: "New FDA Rules make it more difficult for them to speed up vaccines for approval before Election Day. Just another political hit job!"
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
Chinese AI chatbot's rise slams US tech stocks
Speed Read The sudden popularity of a new AI chatbot from Chinese startup DeepSeek has sent U.S. tech stocks tumbling
By Peter Weber, The Week US Published
-
US port strike averted with tentative labor deal
Speed Read The strike could have shut down major ports from Texas to Maine
By Peter Weber, The Week US Published
-
Biden expected to block Japanese bid for US Steel
Speed Read The president is blocking the $14 billion acquisition of U.S. Steel by Japan's Nippon Steel, citing national security concerns
By Peter Weber, The Week US Published
-
Judges block $25B Kroger-Albertsons merger
Speed Read The proposed merger between the supermarket giants was stalled when judges overseeing two separate cases blocked the deal
By Peter Weber, The Week US Published
-
Rupert Murdoch loses 'Succession' court battle
Speed Read Murdoch wanted to give full control of his empire to son Lachlan, ensuring Fox News' right-wing editorial slant
By Peter Weber, The Week US Published
-
Bitcoin surges above $100k in post-election rally
Speed Read Investors are betting that the incoming Trump administration will embrace crypto
By Peter Weber, The Week US Published
-
Enron mystery: 'sick joke' or serious revival?
Speed Read 23 years after its bankruptcy filing, the Texas energy firm has announced its resurrection
By Peter Weber, The Week US Published
-
US charges Indian tycoon with bribery, fraud
Speed Read Indian billionaire Gautam Adani has been indicted by US prosecutors for his role in a $265 million scheme to secure solar energy deals
By Peter Weber, The Week US Published